Eldecalcitol

CAS No.

104121-92-8

MDL No.

MFCD25977156

C₃₀H₅₀O₅

490.70

InChI Key

FZEXGDDBXLBRTD-AYIMTCTASA-N

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

On Request

Custom synthesis and bulk supply options are available upon request.

Product Information

1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 is a hydroxycalciol and tetrol, structurally derived from calcitriol with a 3-hydroxypropoxy group at position 2. It functions as a metabolite and is a member of D3 vitamins.

CAS No.	104121-92-8
Product Name	Eldecalcitol

Biological Targets

VDR

Associated Conditions

osteoporosis

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Documentation

Eldecalcitol

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

Human hepatic metabolism of the anti-osteoporosis drug eldecalcitol involves sterol C4-methyl oxidase.

Eldecalcitol, a vitamin D analog, reduces bone turnover and increases trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.

Eldecalcitol: a review of its use in the treatment of osteoporosis.

Hydrogen/deuterium exchange reveals distinct agonist/partial agonist receptor dynamics within vitamin D receptor/retinoid X receptor heterodimer.

Documentation

Similar Products

Calcitriol